Home » Topics » Conferences

Conferences
RSS

In vitro activity of new glycopeptide from Lilly

July 25, 1997

HRT indicated in hypertensive women

July 25, 1997

HRT inhibits ACE in postmenopausal women

July 25, 1997

New bactericidal antiseptic from Otsuka

July 24, 1997

Potent, orally active azole antifungal from Bayer

July 24, 1997

Quinolones remain at the forefront of antiinfective therapy

July 24, 1997

Antibacterial activity and clinical efficacy of grepafloxacin reported

July 24, 1997

More light shed on leptin and leptin receptors

July 24, 1997

Genetic and molecular pathogenesis of IDDM

July 24, 1997

DU-6859a: dose-finding study in UTI

July 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.